Hepion Pharmaceuticals logo

Hepion Pharmaceuticals Share Price Today (NASDAQ: HEPA)

Hepion Pharmaceuticals share price is 0.32 & ₹27.27 as on 12 May 2025, 09.30 hrs IST

$0.32

-0.07

(-19.05%)

Live

View live Hepion Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Hepion Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Hepion Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Hepion Pharmaceuticals (HEPA) Key Statistics

in dollars & INR

Previous Close
$0.3916
Open
$0.39
Market Capitalization
$3.5M
Today's Volume
$4.0M
Revenue TTM
$0.0
EBITDA
$-19.3M
Earnings Per Share (EPS)
$-5367.5
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-487.03%

How to invest in Hepion Pharmaceuticals Stock (HEPA) from India?

It is very easy for Indian residents to invest directly in Hepion Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Hepion Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Hepion Pharmaceuticals or HEPA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Hepion Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Hepion Pharmaceuticals shares which would translate to 2.663 fractional shares of Hepion Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Hepion Pharmaceuticals, in just a few clicks!

Returns in Hepion Pharmaceuticals (HEPA) for Indian investors in Rupees

The Hepion Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Hepion Pharmaceuticals investment value today

Current value as on today

₹2,618

Returns

₹97,382

(-97.38%)

Returns from Hepion Pharmaceuticals Stock

₹99,471 (-99.47%)

Dollar Returns

₹2,089 (+2.09%)

Indian investors sentiment towards Hepion Pharmaceuticals (HEPA)

-66.15%

Period: Apr 12, 2025 to May 12, 2025. Change in 30 Days versus previous period

Investment in Hepion Pharmaceuticals Shares from India has dropped by -66.15% over the past 30 days, indicating reduced transactional activity.

-75%

Period: Apr 12, 2025 to May 12, 2025. Change in 30 Days versus previous period

Search interest for Hepion Pharmaceuticals Stock from India on INDmoney has decreased by -75% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Hepion Pharmaceuticals

  • Anson Funds Management LP

    0.43%

  • BlackRock Inc

    0.15%

  • Vanguard Group Inc

    0.09%

  • Geode Capital Management, LLC

    0.08%

  • Susquehanna International Group, LLP

    0.05%

  • Renaissance Technologies Corp

    0.03%

Analyst Recommendation on Hepion Pharmaceuticals

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Hepion Pharmaceuticals(by analysts ranked 0 to 5 stars)

Analyst Forecast on Hepion Pharmaceuticals Stock (HEPA)

What analysts predicted

Upside of 9275.0%

Target:

$30.00

Current:

$0.32

Insights on Hepion Pharmaceuticals Stock (Ticker Symbol: HEPA)

  • Price Movement

    In the last 1 month, HEPA stock has moved down by -24.9%
  • HEPA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 79.9% return, outperforming this stock by 179.4%
  • HEPA vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 113.2% return, outperforming this stock by 213.2%

Hepion Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Hepion Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Hepion Pharmaceuticals (HEPA) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Hepion Pharmaceuticals Inc logo
-17.64%
-98.99%
-99.48%
-99.96%
-99.98%
Regeneron Pharmaceuticals, Inc. logo
0.72%
-29.94%
-41.12%
-12.19%
0.76%
Vertex Pharmaceuticals Incorporated logo
-11.36%
-10.31%
2.22%
72.91%
58.66%
Alnylam Pharmaceuticals, Inc. logo
12.33%
0.24%
79.87%
115.9%
97.94%

About Hepion Pharmaceuticals

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC) and other chronic liver diseases in the United States. It develops Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation; liver tumor burden; and titers of HBV, HCV, HDV, and HIV-1. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Morristown, New Jersey.
Organization
Hepion Pharmaceuticals
Employees
0
CEO
Sharen Pyatetskaya
Industry
Health Technology

Management People of Hepion Pharmaceuticals

NameTitle
Sharen Pyatetskaya
Director of Investor Relations

Important FAQs about investing in HEPA Stock from India :

Can Indians buy Hepion Pharmaceuticals shares?

Yes, Indians can invest in the Hepion Pharmaceuticals (HEPA) from India.

With INDmoney, you can buy Hepion Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Hepion Pharmaceuticals at zero transaction cost.

How can I buy Hepion Pharmaceuticals shares from India?

It is very easy to buy Hepion Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Hepion Pharmaceuticals (HEPA) be purchased?

Yes, you can buy fractional shares of Hepion Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Hepion Pharmaceuticals stocks?

To start investing in Hepion Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Hepion Pharmaceuticals share price today?

Hepion Pharmaceuticals share price today stands at $0.32, Open: $0.39 ; Previous Close: $0.39 ; High: {{1_rba_end}} ; Low: {{1_rba_st}} ; 52 Week High: {{rba_end}} ; 52 Week Low: {{rba_st}}.

The stock opens at $0.39, after a previous close of $0.39. The stock reached a daily high of {{1_rba_end}} and a low of {{1_rba_st}}, with a 52-week high of {{rba_end}} and a 52-week low of {{rba_st}}.

What are today’s High and Low prices of Hepion Pharmaceuticals Stock (HEPA)?

Today’s highest price of Hepion Pharmaceuticals (HEPA) is {{1_rba_end}}.

Today’s lowest price of Hepion Pharmaceuticals (HEPA) is {{1_rba_st}}.

What is the 52 Week High and Low Range of Hepion Pharmaceuticals Stock (HEPA)?

  • 52 Week High

    {{rba_end}}

  • 52 Week Low

    {{rba_st}}

What are the historical returns of Hepion Pharmaceuticals (HEPA)?

  • 1 Month Returns

    -17.64%

  • 3 Months Returns

    -98.99%

  • 1 Year Returns

    -99.48%

  • 5 Years Returns

    -99.98%

What is today's market capitalisation of Hepion Pharmaceuticals?

Today's market capitalisation of Hepion Pharmaceuticals HEPA is 3.5M

Who is the Chief Executive Officer (CEO) of Hepion Pharmaceuticals ?

Sharen Pyatetskaya is the current Chief Executive Officer (CEO) of Hepion Pharmaceuticals.